Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CVS | CVS HEALTH CORP | Healthcare | 279,374.0 | $28.9M | 2.73% | -57K | -17.0% | $103.45 | -9.1% |
| 2 | LLY | LILLY ELI & CO | Healthcare | 22,315.0 | $26.8M | 2.53% | -11K | -33.8% | $1199.43 | +5.5% |
| 3 | ALHC | ALIGNMENT HEALTHCARE INC | Healthcare | 997,083.0 | $23.7M | 2.24% | -56K | -5.3% | $23.81 | -45.2% |
| 4 | BIIB | BIOGEN INC | Healthcare | 94,850.0 | $20.5M | 1.93% | -14K | -13.1% | $216.06 | +0.8% |
| 5 | BSX | BOSTON SCIENTIFIC CORP | Healthcare | 450,500.0 | $19.2M | 1.81% | -174K | -27.9% | $42.68 | +18.0% |
| 6 | GH | GUARDANT HEALTH INC | Healthcare | 115,000.0 | $17.3M | 1.63% | -30K | -20.7% | $150.03 | +12.5% |
| 7 | REGN | REGENERON PHARMACEUTICALS | Healthcare | 27,390.0 | $17.1M | 1.61% | -21K | -43.1% | $623.54 | +33.9% |
| 8 | INSM | INSMED INC | Healthcare | 151,960.0 | $16.2M | 1.53% | -8K | -4.9% | $106.62 | +18.6% |
| 9 | TMO | THERMO FISHER SCIENTIFIC INC | Healthcare | 31,580.0 | $15.8M | 1.49% | -10K | -23.6% | $501.36 | +25.5% |
| 10 | AXSM | AXSOME THERAPEUTICS INC. | Healthcare | 63,050.0 | $15.4M | 1.46% | -750.0 | -1.2% | $244.77 | -14.9% |
| 11 | VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | 30,685.0 | $15.2M | 1.44% | -13K | -29.4% | $496.73 | +9.5% |
| 12 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 85,841.0 | $14.5M | 1.37% | -15K | -14.9% | $168.53 | -8.5% |
| 13 | ISRG | INTUITIVE SURGICAL INC | Healthcare | 34,500.0 | $13.7M | 1.29% | -2K | -6.4% | $397.68 | -1.5% |
| 14 | — | CENCORA INC | — | 46,778.0 | $13.2M | 1.25% | -6K | -10.7% | $282.98 | — |
| 15 | MCK | MCKESSON CORP | Healthcare | 16,550.0 | $12.5M | 1.18% | -300.0 | -1.8% | $755.60 | +12.4% |
| 16 | OSCR | OSCAR HEALTH INC | Healthcare | 392,000.0 | $11.2M | 1.05% | -268K | -40.6% | $28.52 | +15.9% |
| 17 | RPRX | ROYALTY PHARMA PLC | Healthcare | 197,000.0 | $11.0M | 1.04% | -36K | -15.4% | $56.07 | +9.0% |
| 18 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 128,000.0 | $10.4M | 0.98% | -16K | -11.4% | $81.51 | +5.6% |
| 19 | ABT | ABBOTT LABORATORIES | Healthcare | 96,000.0 | $8.7M | 0.82% | -16K | -14.3% | $90.74 | +26.5% |
| 20 | PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | 345,000.0 | $7.8M | 0.73% | -130K | -27.4% | $22.58 | -3.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.4%